These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


48 related items for PubMed ID: 3178238

  • 1. [Drug sensitivity and cellular potassium release of cancer cells].
    Iwagaki H, Fuchimoto S, Aoki H, Miyake M, Orita K.
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2889-93. PubMed ID: 3178238
    [Abstract] [Full Text] [Related]

  • 2. [Monitoring of the effect of anticancer drugs on the membrane potential and cytoplasmic free calcium ion mobilization in cancer cells as a drug sensitivity test].
    Iwagaki H, Fuchimoto S, Miyake M, Orita K.
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2725-30. PubMed ID: 2458072
    [Abstract] [Full Text] [Related]

  • 3. [Experimental and clinical study in vitro chemosensitivity test for succinate dehydrogenase inhibition test].
    Maehara Y, Takeuchi H, Inutsuka S, Baba H, Kohnoe S, Sugimachi K.
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):455-60. PubMed ID: 8452383
    [Abstract] [Full Text] [Related]

  • 4. [Study of in vitro cancer sensitivity of anticancer drugs by SDI (succinate dehydrogenase inhibition test)].
    Kikuchi Y.
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2757-62. PubMed ID: 7993111
    [Abstract] [Full Text] [Related]

  • 5. The membrane potential of Ehrlich ascites tumor cells: an evaluation of the null point method.
    Smith TC, Robinson SC.
    J Cell Physiol; 1981 Mar; 106(3):399-406. PubMed ID: 7217220
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM.
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [Abstract] [Full Text] [Related]

  • 7. [In vitro chemosensitivity test: succinate dehydrogenase inhibition (SDI) test].
    Maehara Y, Kohnoe S, Emi Y, Sakaguchi Y, Sugimachi K.
    Rinsho Byori; 1990 Jan; 38(1):14-8. PubMed ID: 2308218
    [Abstract] [Full Text] [Related]

  • 8. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
    Ali SM, Olivo M.
    Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification.
    Furlong IJ, Lopez Mediavilla C, Ascaso R, Lopez Rivas A, Collins MK.
    Cell Death Differ; 1998 Mar; 5(3):214-21. PubMed ID: 10200467
    [Abstract] [Full Text] [Related]

  • 10. The potassium permeability of pancreatic islet cells: mechanisms of control and influence on insulin release.
    Henquin JC.
    Horm Metab Res Suppl; 1980 Mar; Suppl 10():66-73. PubMed ID: 7005065
    [Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
    Azuma H, Takahara S, Horie S, Muto S, Otsuki Y, Katsuoka Y.
    J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin A does not protect the disruption of the inner mitochondrial membrane potential induced by potassium ionophores in intact K562 cells.
    Marques-Santos LF, Coqueiro VM, Rumjanek VM.
    Cell Biol Int; 2006 Mar; 30(3):197-204. PubMed ID: 16376584
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
    Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, Stöckle M.
    Eur Urol; 2006 Jul; 50(1):141-7. PubMed ID: 16476519
    [Abstract] [Full Text] [Related]

  • 14. Potentiometric platform for the quantification of cellular potassium efflux.
    Generelli S, Jacquemart R, de Rooij NF, Jolicoeur M, Koudelka-Hep M, Guenat OT.
    Lab Chip; 2008 Jul; 8(7):1210-5. PubMed ID: 18584100
    [Abstract] [Full Text] [Related]

  • 15. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW, Mao X, Au PY, Hedley DW, Chow S, Dalili S, Mocanu JD, Bastianutto C, Schimmer A, Liu FF.
    Clin Cancer Res; 2006 Sep 15; 12(18):5557-69. PubMed ID: 17000693
    [Abstract] [Full Text] [Related]

  • 16. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
    Lee CS, Kim YJ, Lee MS, Han ES, Lee SJ.
    Life Sci; 2008 Sep 26; 83(13-14):481-9. PubMed ID: 18721818
    [Abstract] [Full Text] [Related]

  • 17. [Fundamental study on the sensitivity test inhibiting fibroblast proliferation].
    Kondo T, Sato Y, Yamada F.
    Gan To Kagaku Ryoho; 2001 May 26; 28(5):669-75. PubMed ID: 11383216
    [Abstract] [Full Text] [Related]

  • 18. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.
    Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S, Fojo T.
    J Clin Invest; 1995 May 26; 95(5):2205-14. PubMed ID: 7738186
    [Abstract] [Full Text] [Related]

  • 19. Association of BCL-2 with membrane hyperpolarization and radioresistance.
    Gilbert MS, Saad AH, Rupnow BA, Knox SJ.
    J Cell Physiol; 1996 Jul 26; 168(1):114-22. PubMed ID: 8647905
    [Abstract] [Full Text] [Related]

  • 20. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, Piechota H, Hertle L.
    Aktuelle Urol; 2004 Aug 26; 35(4):331-8. PubMed ID: 15459875
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.